ArticleAging cell2025
The m6A Demethylase Fto Enhances Susceptibility to Atrial Fibrillation by Demethylating Kcne1 in Aging Mice.
Article in Aging cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fto-mediated m6A demethylation of Lox drives atrial fibrosis and promotes atrial fibrillation in a murine model of hyperthyroidism.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026Article
- FTO in cardiovascular diseases: mechanisms, context dependence, and translational opportunities.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Aging is a risk factor for atrial fibrillation (AF). In 19-month-old mice, increases in AF inducibility are associated with enhanced protein levels of fat mass and obesity-associated protein (Fto), and reduced N6-methyladenosine (m6A) modification in atrial tissue. Whether Fto-regulated m6A demethylation is involved in aging-induced AF remains unclear. AF inducibility and electrophysiology were performed through programmed stimulation and optical mapping. The intensities of slow delayed rectifier potassium currents (IKs) were measured by patch-clamp. m6A-sequencing revealed that Kcne1 mRNA was m6A-demethylated in aging mouse atria. Kcne1 knockdown in 2-month-old mice increased AF inducibility. Aging mice with cardiomyocyte-specific Fto knockout had increased Kcne1 mRNA and protein levels, with reduced susceptibility to AF. Additionally, overexpression of wild-type Fto, rather than a catalytically inactive mutant in 2-month-old mice, reduced Kcne1 protein levels, leading to enhanced IKs current and AF inducibility. Furthermore, the negative relationship between FTO and KCNE1 was confirmed in left atrial appendage samples from AF patients. In iPSC-derived atrial cardiomyocytes, FTO-mediated KCNE1 demethylation repressed KCNE1 pre-mRNA splicing, mRNA nuclear export, and translational efficacy. Collectively, aging-induced elevation of Fto represses m6A methylation of Kcne1, which in turn leads to reductions in Kcne1 mRNA and protein levels in atrial cardiomyocytes, thereby increasing AF inducibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.